| 22nd Apr 2020 11:00 am |
RNS |
COVID-19 Project Initiated |
| 21st Apr 2020 2:26 pm |
RNS |
Approval and Issuance of European Hu-PHEC Patent |
| 2nd Apr 2020 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 2nd Apr 2020 2:00 pm |
RNS |
Price Monitoring Extension |
| 28th Feb 2020 6:30 pm |
RNS |
Total Voting Rights |
| 20th Feb 2020 7:00 am |
RNS |
HEMO-CAR-T cells Effective Against AML in vivo |
| 20th Feb 2020 7:00 am |
RNS |
HEMO-CAR-T cells Effective Against AML in vivo |
| 11th Feb 2020 7:00 am |
RNS |
Approval and Issuance of U.S. Hu-PHEC Patent |
| 31st Jan 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 30th Jan 2020 2:05 pm |
RNS |
Placing and Subscription to raise £650,000 |
| 15th Jan 2020 12:30 pm |
RNS |
HEMO's CAR-T Cells Effective Against AML in vitro |
| 18th Nov 2019 7:00 am |
RNS |
Operational Update |
| 12th Nov 2019 7:00 am |
RNS |
Presentation at the Investival Showcase |
| 6th Nov 2019 7:00 am |
RNS |
Presentation at the NY Oncology Investor Conf. |
| 23rd Oct 2019 7:00 am |
RNS |
Research Agreement with Global Pharma Company |
| 21st Oct 2019 7:00 am |
RNS |
Presentation at NY Stem Cell Foundation conference |
| 30th Sep 2019 7:00 am |
RNS |
Half-year Report |
| 12th Sep 2019 7:00 am |
RNS |
Hemogenyx scientific advisor receives Lasker Award |
| 1st Aug 2019 7:00 am |
RNS |
Total Voting Rights |
| 12th Jul 2019 7:00 am |
RNS |
CDX Patent Application |
| 3rd Jul 2019 7:00 am |
RNS |
Director/PDMR Shareholding |
| 28th Jun 2019 12:19 pm |
RNS |
Result of AGM |
| 24th Jun 2019 7:00 am |
RNS |
Development of ApbHC |
| 12th Jun 2019 7:00 am |
RNS |
CDX Effective as Conditioning Therapeutic in vivo |
| 5th Jun 2019 8:15 am |
RNS |
CDX Antibody is Effective against AML in vivo |
| 30th May 2019 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 30th May 2019 4:35 pm |
RNS |
Price Monitoring Extension |
| 30th May 2019 7:00 am |
RNS |
CDX Antibody is Effective against ALL in vitro |
| 28th May 2019 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
| 15th May 2019 7:00 am |
RNS |
Variation of Terms of Warrant Instrument |
| 1st May 2019 7:00 am |
RNS |
Director/PDMR Shareholding |
| 29th Apr 2019 3:10 pm |
RNS |
Final Results for the Year Ended 31 December 2018 |
| 30th Jan 2019 7:00 am |
RNS |
Presentation at Cancer Immunotherapy Conference |
| 7th Jan 2019 7:00 am |
RNS |
Operations Update |
| 20th Dec 2018 7:00 am |
RNS |
Directorate Change |
| 5th Nov 2018 7:00 am |
RNS |
Directorate Change & Appointment |
| 22nd Oct 2018 7:00 am |
RNS |
Orgenesis collaboration for Hu-PHEC development |
| 19th Oct 2018 7:00 am |
RNS |
Collaboration, License and Investment by Orgenesis |
| 15th Oct 2018 7:00 am |
RNS |
Collaboration with Johnson & Johnson Innovation |
| 28th Sep 2018 9:30 am |
RNS |
Half-year Report |
